Print

TG Therapeutics, Inc. (MHA) to Present at the 31st Annual J.P. Morgan Healthcare Conference  
1/7/2013 9:54:12 AM

NEW YORK, Jan. 7, 2013 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX) today announced that Michael Weiss, the Company's Interim Chief Executive Officer, will be presenting at the 31st Annual J.P. Morgan Healthcare Conference, being held at the Westin St. Francis Hotel in San Francisco. Mr. Weiss will discuss updates on the Company's two lead compounds for hematologic malignancies; TG-1101 (ublituximab) and TGR-1202. The presentation is scheduled to take place on Thursday, January 10, 2013 at 2:00 PM PST. A live webcast of this presentation will be available on the Events page of the Company's website at www.tgtherapeutics.com.
//-->